Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|December 10, 2003
G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawalGregory W Terman, Wenzhen Jin, Young-Pyo Cheong, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 8, 2012
Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanismJulia C Lemos, Clarisse A Roth, Daniel I Messinger, et al.
Behavioural Brain Research|November 9, 2011
Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesisSarah L Hays, Ronald J McPherson, Sandra E Juul, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 20, 2008
Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine systemArati Kreibich, Beverly A S Reyes, Andre L Curtis, et al.
Neuron|December 28, 2019
Synergy of Distinct Dopamine Projection Populations in Behavioral ReinforcementGabriel Heymann, Yong S Jo, Kathryn L Reichard, et al.
The Journal of Pain|October 24, 2007
Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal ratsLisa M Thomson, Gregory W Terman, Jinsong Zeng, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 26, 2021
Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT1B receptorsHarrison M Fontaine, Phillip R Silva, Carlie Neiswanger, et al.
Neuron|November 12, 2013
Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutationMarta E Soden, Graham L Jones, Christina A Sanford, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerationsCharles Chavkin, Sumit Sud, Wenzhen Jin, et al.
Pageof 8